This basic science study identifies a calbindin 9K binding domain in the plasma membrane Ca2+ pump, showing it has lower affinity than calmodulin.
No direct clinical implications from this animal study; leaves open calbindin 9K's role in calcium homeostasis.
Bovine calbindin 9K has been conjugated to a bifunctional, photoactivatable, cleavable and radioactive cross-linker. It has been photolyzed in the presence of preparations of the purified erythrocyte Ca2+ pump, and shown to interact with it in the presence of Ca2+. The affinity of the interaction has been studied using the fluorescence enhancement of dansylated calbindin 9K incubated with the synthetic calmodulin binding domain of the pump. Two versions of the domain have been used, one corresponding to its full length (28 residues), one to about 2/3 of it (20 residues). The affinity of the interaction was between 5 and 10 times lower than in the case of calmodulin.
No takes yet. Share an insight, caveat, or question.
James et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: